We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

Back to rankings

42 hedge funds and large institutions have $51.2M invested in BIND THERAPEUTICS INC in 2013 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,850% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 2

740% more funds holding

Funds holding: 5 → 42 (+37)

249% more capital invested

Capital invested by funds: $14.7M → $51.2M (+$36.6M)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

Holders
42
Holders Change
+37
Holders Change %
+740%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$5.76M
2
Franklin Resources
Franklin Resources
California
+$4.31M
3
Principal Financial Group
Principal Financial Group
Iowa
+$3.99M
4
PI
Putnam Investments
Massachusetts
+$3.82M
5
DM
Deerfield Management
New York
+$3.26M

Top Sellers

Rank Fund Capital Flow
1
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$6.35M
2
WSA
Wall Street Associates
California
-$1.76M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$514K
Name Holding Trade Value Shares
Change 		Change in
Stake
EMFAT
1
Emerald Mutual Fund Advisers Trust
Pennsylvania
$8.43M +$5.76M +452,717 +299%
EA
2
Emerald Advisers
Pennsylvania
$6.33M +$2.67M +209,612 +100%
Franklin Resources
3
Franklin Resources
California
$5.11M +$4.31M +338,800 New
Principal Financial Group
4
Principal Financial Group
Iowa
$4.73M +$3.99M +313,517 New
PI
5
Putnam Investments
Massachusetts
$4.53M +$3.82M +300,000 New
DM
6
Deerfield Management
New York
$3.87M +$3.26M +256,384 New
BI
7
BVF Inc
California
$2.26M +$1.91M +150,000 New
BFA
8
BlackRock Fund Advisors
California
$2.13M +$1.79M +141,036 New
OM
9
Opaleye Management
Massachusetts
$2.12M +$1.97M +155,000 New
BIT
10
BlackRock Institutional Trust
California
$1.23M +$1.03M +81,170 New
Northern Trust
11
Northern Trust
Illinois
$1.13M +$955K +75,044 New
Millennium Management
12
Millennium Management
New York
$1.09M +$922K +72,495 New
CS
13
Credit Suisse
Switzerland
$1.02M +$862K +67,733 New
Alyeska Investment Group
14
Alyeska Investment Group
Illinois
$937K -$514K -40,413 -39%
Vanguard Group
15
Vanguard Group
Pennsylvania
$920K +$776K +60,959 New
RA
16
Royce & Associates
New York
$830K +$700K +55,000 New
State Street
17
State Street
Massachusetts
$526K +$443K +34,811 New
RJA
18
Raymond James & Associates
Florida
$505K +$426K +33,450 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$460K +$388K +30,526 New
Deutsche Bank
20
Deutsche Bank
Germany
$385K +$326K +25,602 New
SIM
21
SSI Investment Management
California
$356K +$300K +23,580 New
PAM
22
Panagora Asset Management
Massachusetts
$335K +$282K +22,179 New
TC
23
TFS Capital
Pennsylvania
$316K +$266K +20,933 New
TCIM
24
TIAA CREF Investment Management
New York
$215K +$182K +14,274 New
BA
25
BlackRock Advisors
Delaware
$208K +$175K +13,764 New
1
2

BIND Hedge Fund Activity: Q4 2013 in Review

42 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q4 2013, worth a combined $51.2M — up 249% from $14.7M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new BIND positions and 2 closed out — a net gain of 37 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Emerald Mutual Fund Advisers Trust, adding an estimated $5.76M. The largest seller was Bain Capital Public Equity Management, exiting entirely with an estimated $6.35M sold.

  • 42 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q4 2013, up from 5 in Q3 2013.
  • Funds reported $51.2M of BIND THERAPEUTICS INC stock for Q4 2013, up 249% quarter-over-quarter.
  • 39 funds opened new BIND THERAPEUTICS INC positions in Q4 2013 and 2 closed out, a net change of +37 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q4 2013 was Emerald Mutual Fund Advisers Trust, an estimated $5.76M added.
  • The largest BIND THERAPEUTICS INC seller in Q4 2013 was Bain Capital Public Equity Management, an estimated $6.35M sold.

Based on aggregated 13F filings for Q4 2013.